SMX

Business Context and Reporting Period

Company: SMX (Security Matters) Public Limited Company
Filing Type: Form 6-K (Current Report of Foreign Private Issuer)
Reporting Period: Six months ended June 30, 2024
Business Overview: SMX develops track-and-trace technologies using sub-molecular markers to ensure supply chain integrity, material provenance, and ESG compliance. The company aims to facilitate the transition to a circular economy, including initiatives like a "Plastic Cycle Token."

Key Financial Metrics

Debt and Liquidity: As of June 30, 2024, the company had no cash and a $21 thousand overdraft. The company has outstanding payables of approximately $15 million related to Business Combination expenses. Post-period, the company raised approximately $6.3 million in funding (July–September 2024) and restructured $1.3 million of debt.

Material Changes vs. Prior Period

• Operating Loss Reduction: Operating loss decreased by 71% (from $31.6M to $9.3M). This improvement is primarily due to the absence of one-time Business Combination listing costs ($16.8M) and transaction expenses ($7.8M) incurred in the prior period.
• Expense Shifts:
  • R&D Expenses: Increased 44% to $1.7M, driven by subcontractor costs for a NATO project and headcount increases in Singapore.
  • Selling & Marketing: Increased 1,093% to $2.7M, attributed to third-party marketing and digital branding services.
  • G&A Expenses: Decreased 64% to $4.8M, largely due to the reduction in transaction and listing costs from the prior year.
• Finance Costs: Net finance expenses increased to $1.6M (expenses of $3.2M less income of $1.6M), driven by interest on promissory notes and warrant revaluations.

Outlook, Risks, and Contingencies

Going Concern Warning

The financial statements include an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern. The company has incurred accumulated losses of $61.6 million, has no cash on hand as of June 30, 2024, and relies on continuous capital raises to fund operations and repay obligations.

Recent Capital Raises (Post-Period)

• September 2024: Raised $5.35 million via a private placement of Common Units (shares and warrants).
• August 2024: Raised $194.5 thousand via a promissory note.
• July 2024: Raised $747.5 thousand via a promissory note and warrants.
• SPA: Has a $30 million equity line of credit with Generating Alpha.

Material Risks and Contingencies

• Contract Dispute: A $5 million contract with R&I Trading (for a NATO member state) was terminated by the counterparty in July 2024, leading to a demand for arbitration. Management disputes the termination but notes the outcome is uncertain.
• Listing Status: The company executed a 75:1 reverse stock split in July 2024 to meet Nasdaq minimum bid price requirements. Failure to maintain compliance could result in delisting.
• Geopolitical Risk: Operations in Israel face risks from ongoing hostilities.
• Liquidity Risk: The company is negotiating with debt holders to extend terms or convert debt to equity. There is no assurance that additional funding will be available on acceptable terms.

Investor Verification Checklist

• Cash Runway: Verify the current cash balance post-September 2024 funding and the burn rate to assess immediate liquidity needs.
• Revenue Recognition: Confirm the status of the $5 million R&I Trading contract and whether any revenue can be recognized despite the dispute.
• Debt Conversion: Review the terms of the recent promissory notes and the $30M SPA to understand potential dilution to existing shareholders.
• Nasdaq Compliance: Monitor the stock price to ensure it remains above the $1.00 minimum bid price following the reverse split.
• Going Concern Status: Assess the likelihood of the company securing further capital before existing cash reserves are depleted.